Results 11 to 20 of about 175,482 (262)

Potency and breadth of human primary ZIKV immune sera shows that Zika viruses cluster antigenically as a single serotype. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2020
Zika virus (ZIKV) emerged as a global public health threat throughout the Americas since 2014. Phylogenetically, the virus is composed of three main lineages, an African, Asian, and American lineage.
Chad D Nix   +6 more
doaj   +2 more sources

DIFFERENTIAL CROSS-NEUTRALIZATION OF DENGUE IMMUNE SERA AGAINST ZIKA VIRUS

open access: yesInternational Journal of Infectious Diseases, 2023
Intro: Zika virus (ZIKV) is transmitted to humans primarily via the bites of infected female Aedes aegypti and Aedes albopictus. The mosquitoes are also the vector for the transmission of dengue viruses. Malaysia is a dengue hyperendemic country. To date,
J.-Y. Tan, K.-K. Tan, S. AbuBakar
doaj   +1 more source

Passive Immunity and Antibody Response Induced by Toxoplasma gondii VLP Immunization

open access: yesVaccines, 2021
Passive immunity can provide immediate protection against infectious pathogens. To date, only a few studies have investigated the effect of passive immunization against Toxoplasma gondii, and the use of immune sera acquired from VLP-vaccinated mice for ...
Hae-Ji Kang   +5 more
doaj   +1 more source

Antivinculin antibodies in sera of patients with immune thrombocytopenia and in sera of normal subjects [PDF]

open access: yesBlood, 1992
Abstract We have characterized a 120-Kd antigen that frequently reacts with serum antibodies from patients with immune thrombocytopenia or normal subjects. Immunoblots made after two-dimensional nonreduced/reduced sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) or two-dimensional isoelectric focusing/SDS-PAGE ...
Y, Tomiyama   +3 more
openaire   +3 more sources

Antibody landscape of C57BL/6 mice cured of B78 melanoma via a combined radiation and immunocytokine immunotherapy regimen

open access: yesFrontiers in Immunology, 2023
Sera of immune mice that were previously cured of their melanoma through a combined radiation and immunocytokine immunotherapy regimen consisting of 12 Gy of external beam radiation and the intratumoral administration of an immunocytokine (anti-GD2 mAb ...
Anna Hoefges   +20 more
doaj   +1 more source

STUDY OF IMMUNOGENICITY OF A PROTOTYPE VACCINE AGAINST HEPATITIS E

open access: yesЖурнал микробиологии, эпидемиологии и иммунобиологии, 2017
Aim. Evaluate specific immunogenic activity of a prototype vaccine against hepatitis E (HE). Materials and methods. Non-linear mice, male (n=170), were immunized once intraperitoneally by a prototype vaccine against HE at 5,10 and 20 pg per animal.
S. L. Gulyaev   +8 more
doaj   +1 more source

Development of the scheme of obtaining antibodies to the ribonucleoprotein of attenuated rabies virus

open access: yesЖурнал микробиологии, эпидемиологии и иммунобиологии, 2019
Aim. Isolation of ribonucleoprotein (RNP) of an attenuated rabies virus, develop schemes for immunizing animals with RNP-based preparations and determine the most effective scheme that allows obtaining serum with a high antibody titer to the RNP ...
Yu. K. Gavrilova   +8 more
doaj   +1 more source

IMMUNE SERA. [PDF]

open access: yesJournal of the American Chemical Society, 1904
n ...
openaire   +1 more source

Development of New Approaches of Obtaining the Hyperimmune Sera for Production of Medical Immunobiological Preparations

open access: yesПроблемы особо опасных инфекций, 2010
Developed were the new immunization schedules of obtaining plague, brucellar, anthrax, tularemia, cholera, leptospirosis, legionellosis and campilobacteriosis hyperimmune sera based on optimal combinations of specific protein antigenic complexes with ...
E. N. Afanasiev   +6 more
doaj   +1 more source

H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer model. [PDF]

open access: yesPLoS ONE, 2011
Vero cell culture-derived whole-virus H5N1 vaccines have been extensively tested in clinical trials and consistently demonstrated to be safe and immunogenic; however, clinical efficacy is difficult to evaluate in the absence of wide-spread human disease.
M Keith Howard   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy